MTAP-deleted NSCLC
Oncology·MeSH: Neoplasms
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| anvumetostat | AMGEN INC (AMGN) |
Frequently asked questions
How many drugs are in development for MTAP-deleted NSCLC?
BioSniper tracks 1 drug in development for MTAP-deleted NSCLC across 1 company.
How many clinical trials target MTAP-deleted NSCLC?
There are 1 clinical trial targeting MTAP-deleted NSCLC tracked by BioSniper.
Deep-dive into MTAP-deleted NSCLC
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis